Diabetes shot boosts motor function for patients with Parkinson’s 

The results of a Parkinson’s disease clinical trial suggest that the type 2 diabetes drug exenatide may work as a treatment that can slow or even stop the disease. Patients who injected the drug every week for 48 weeks performed better in movement tests than those who injected a placebo.

Read more